Introduction {#sec1}
============

It is well acknowledged that bacteria are able to secrete extracellular vesicles (EVs) in the surrounding environment and that these vesicles are employed to communicate with other cells ([@ref42]; [@ref18]; [@ref35]). Just like human cells that produce extracellular vesicles (referred as exosomes), Gram-negative bacteria release vesicles that are named outer membrane vesicles (OMVs).

Dick Hoekstra was one of the first researchers to discover vesicles from *Escherichia coli* in 1976, characterize them, and report a freeze-fracture electron micrograph of OMVs ([@ref29]). In the following years, vesicles were also discovered in Gram-positive bacteria ([@ref11]), and novel types of outer membrane vesicles were continuously discovered ([@ref56]).

OMVs are small vesicles with a diameter ranging from 20 to 200 nm, which contain proteins, lipids, nucleic acids, and other bacterial metabolites. These vesicles have interesting properties, especially when they interact with human cells; they can deliver functional molecules to host cells, acting as nanosized delivery vectors and adjuvants in immunization strategies and likely participating in cell-to-cell communication processes ([@ref2]; [@ref64]). Interestingly, small RNAs (sRNAs) contained within OMVs have been considered as candidate interspecies-communication molecules due to their demonstrated capacity to modulate gene expression in multiple cell types and species ([@ref37]; [@ref15]). One of the main functions of OMVs is not only to transport but also to protect their content (in particular sRNAs) from RNAses present in the extracellular environment and to allow them to reach the host cell ([@ref37]; [@ref43]). Therefore, OMVs have recently received growing attention, especially for the suggested gene-regulatory roles of their sRNAs content. However, how OMVs interact with human cells, the precise mechanisms of internalization into the host cells, and the regulatory function of sRNAs remain an under-investigated area of research, especially in the context of gut microbiota field ([@ref3]).

In order to contribute to understanding a part of the overall picture, in this review, we will briefly summarize the current findings of Gram-negative bacterial OMVs, especially by focusing on their sRNAs content, their function, and their modulatory role in the interaction with the host. Therefore, we will discuss our opinion on what should be discovered in the field of bacterial OMVs and prompt the investigations toward the complete elucidation of the roles and functions of these vesicles and their sRNAs.

Bacterial sRNAs {#sec2}
===============

In eukaryotes, small RNAs such as siRNAs and miRNAs that act as antisense regulators share common biogenesis and functional protein components ([@ref21]). In prokaryotes, sRNAs are structurally very heterogeneous and different in size but conserved in closely related pathogens ([@ref10]).

Many of these sRNAs have an assigned cellular function that somehow classifies them into different functional categories ([@ref74]). Bacterial sRNAs have many regulatory mechanisms. Bacterial sRNAs can bind to protein targets and modify their functions such as *MicF* RNA of *E. coli* that represses the production of the outer membrane protein *OmpF* ([@ref19]) or *CsrB* and *CrsC* RNAs that bind the CsrA protein and reduce its activity by sequestering it from its targets ([@ref45]). To regulate gene expression, bacterial sRNAs can bind to the Hfq protein (somehow similar to the RISC complex in eukaryotes) and exploit RNA base pairing to regulate the expression of target microRNAs (mRNAs). Hfq is a highly conserved and very abundant protein that has implications in a number of RNA-mediated events ([@ref50]; [@ref79]). Finally, sRNAs can unmask or block the ribosome-binding site ([@ref75]).

Bacterial sRNAs (i.e., tRNA fragments) can be internalized within extracellular vesicles, released in the surrounding environment, and transferred to other microbes and host cells ([@ref37]; [@ref69]; [@ref43]) as already reported by the protozoan pathogen *Trypanosoma cruzi* ([@ref23]). However, intracellular bacterial pathogens can express sRNAs that have regulatory functions similarly to miRNAs. In fact, after the infection of human THP-1 macrophage cells with the *Mycobacterium marinum*, the authors observed the production of sRNAs able to bind the host RNA-induced silencing complex (RISC) that interfered with the miRNA-mediated post-trascriptional gene regulation ([@ref22]). Also the fungal pathogen *Botrytis cinereal* has virulent sRNAs that can bind RISC and inhibit host-immunity genes ([@ref76]). Moreover, the sRNA *PinT* produced by the intracellular pathogen *Salmonella enterica* has been demonstrated to regulate the expression of host genes and mediate the activity of invasion-associated bacterial effectors and virulence genes required for intracellular survival ([@ref77]).

Finally, periodontal pathogens have been reported to produce miRNA-sized sRNAs (msRNAs) that can be packed in OMVs and transferred into eukaryotic cells (i.e., in T lymphocytes) and induce the production of cytokines such as IL-5, IL-13, and IL-15 ([@ref15]). Similarly, the *Pseudomonas aeruginosa*-derived methionine tRNA can be conveyed by OMVs into human epithelial airway cells and decreases the secretion of IL-8 ([@ref37]).

Therefore, all of these studies emphasize the importance of microbial sRNAs as crucial communication molecules that are able to mediate host-microbe interactions.

Biogenesis of OMVs {#sec3}
==================

To our knowledge, there are four main proposed mechanisms for OMVs biogenesis ([@ref58]; [@ref31]). The first model is based on the loss or rearrangement of covalent linkages between the outer membrane (OM) molecules and the underlying peptidoglycan (PG) layer allowing OM to protrude and generate OMV ([@ref41]; [@ref40]). The second model hypothesizes the generation of a higher pressure inside the periplasmic space owing to the accumulation of peptidoglycan fragments or misfolded proteins in the periplasmic space that causes the OM to bulge ([@ref28]). The third suggested mechanism takes into account the enhancement of the B band lipopolysaccharide and the *Pseudomonas* quinolone signal (PQS) considered to be crucial for membrane curvature in *P. aeruginosa* and for the formation of OMVs ([@ref41]; [@ref63]). Finally, the fourth model comes from the observation that the repression or abolishment of *VacJ/Yrb*, two genes associated with the transport and accumulation of phospholipids in the outer leaflet of OM, led to an asymmetric expansion of the outer leaflet together with a bulging of the OM and OMVs production in some Gram-negative bacteria ([@ref60]).

OMVs biogenesis is modulated by growth conditions ([@ref62]) and by a different bacterial gene expression ([@ref49]; [@ref24]). Nutrients availability is another factor that could influence OMVs biogenesis. In fact, *Lysobacter* sp., and *Pseudomonas fragi* release more OMVs in response to a small or large amount of nutrients, respectively ([@ref68]; [@ref72]).

In Gram-negative bacteria, the overproduction of OMVs is mediated by sRNAs through a conserved mechanism ([@ref5]; [@ref66]). In fact, the overexpression of *VrrA* in *Vibrio cholerae*, that has sRNAs homologs in *E. coli*, *S. enterica* serovar Typhimurium (*S.* Typhimurium), *Yersinia pestis*, and *Klebsiella pneumoniae*, increased the vesiculation by downregulating OmpA, a protein connecting OM to PG ([@ref5]; [@ref66]).

Different mechanisms for the selection of small RNA and miRNAs sorting into mammalian EVs have been proposed ([@ref1]). These include the presence of a particular motif on the miRNA sequences ([@ref7]) that facilitate the sorting into EVs by ribonucleoproteins (i.e., hnRNPA2B1), the posttranscriptional modifications of miRNAs (i.e., 3\' end uridylation), or the active involvement of crucial proteins for EVs biogenesis such as nSMase2 and AGO2.

Conversely, very little is known regarding the effect of bacterial processes and proteins involved in the selective packaging of RNA molecules into OMVs. We know that OMV biogenesis is linked to RNA packaging and sorting processes and that this process is regulated by different culture conditions ([@ref47]). However, although during OMVs biogenesis there is a selective packaging of specific RNAs similar to that of mammalian exosomes, to our knowledge the precise sorting mechanism has never been described so far.

Characterization of the RNA Content of Bacterial OMVs {#sec4}
=====================================================

OMVs can be typically separated from cell-free culture supernatants, liquid cultures, or body fluids ([@ref32]) by differential centrifugation steps, filtration (through 0.22--0.45 μm porosity filters), and ultracentrifugation ([@ref51]; [@ref17]) although this isolation method does not completely remove small contaminants such as protein aggregates or membrane debris ([@ref36]). Gel filtration and density gradient ultracentrifugation are other two widely employed procedures to isolate and purify Gram-negative OMVs ([@ref53]; [@ref16]; [@ref71]; [@ref4]; [@ref38]). More recently, another ultrafiltration method through a tangential flow filtration (TFF) apparatus coupled to ultracentrifugation/washing steps has been adopted to obtain a concentrated pellet of OMVs ([@ref62]).

The analysis of the inner content confirmed that these OMVs are heterogeneous nanostructures that are able to pack and transport many bacterial products and small molecules such as proteins, lipopolysaccharides (LPS), DNA fragments, and also sRNAs ([@ref78]; [@ref59]; [@ref61]; [@ref37]; [@ref8]; [@ref55]).

Many previous studies focused on the identification and study of OMV-associated proteins as these proteins significantly contribute to the structure and functions of Gram-negative bacterial vesicles ([@ref34]; [@ref6]; [@ref67]; [@ref73]). However, only recently the interest has focused also on the sRNAs content for their possible modulatory role. [Table 1](#tab1){ref-type="table"} reports the main papers dealing with this topic that we will discuss below. Although previous studies suggested that vesicles produced by *E. coli* and *Streptococcus mutans* contain "microRNA-like" molecules ([@ref44]; [@ref33]), the structures of these sRNAs are substantially different from eukaryotes' microRNAs. In fact, these molecules have bulges, but not 3\' overhangs, that represent two important features for mediating gene expression regulation. Ghosal and collaborators characterized the extracellular components of the OMVs of *E. coli* substrain MG1655, and they accurately described the presence of small non-coding RNAs (sRNAs; [@ref25]). In the same year, other works emphasized the role of sRNAs and OMVs in *V. cholerae* ([@ref65]). In other pathogenic bacteria, such as the uropathogenic *E. coli* strain 536 and *P. aeruginosa*, independent evidence has revealed the presence of secretory bacterial sRNAs within OMVs ([@ref9]; [@ref37]). More recently, also periodontal pathogens, such as *Aggregatibacter actinomycetemcomitans*, *Porphyromonas gingivalis*, and *Treponema denticola*, have been reported to secrete sRNAs in OMVs ([@ref14]). Similarly, OMVs secreted by *S.* Typhimurium were characterized, revealing the presence of RNAs. The analysis of the RNA fraction showed that part of the extracellular RNA content is made by mRNAs and other non-coding RNAs that were specifically enriched in OMVs ([@ref47]). In fact, the authors demonstrated that these sRNAs packed inside OMVs were not degraded by RNAse or proteinases as the RT-PCR of non-coding regulatory RNAs was not inhibited.

###### 

Papers covering the isolation, identification and characterization of OMV-derived sRNAs.

  Organism                                                                                       sRNAs species identified                                                                                                                                                                                                                                                                                                                                                                                                                   Followed approach            Reference
  ---------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ---------------------------- -----------
  *Escherichia coli*                                                                             The authors identified sRNAs that they called "microRNA-like" molecules. These molecules are similar to eukaryotes' miRNAs: they have bulges but not 3\' overhangs.                                                                                                                                                                                                                                                                        High-throughput sequencing   [@ref33]
  *Streptococcus mutans*                                                                         The authors identified sRNAs that they called "microRNA-like" molecules. These molecules are similar to eukaryotes' miRNAs: they have bulges but not 3\' overhangs.                                                                                                                                                                                                                                                                        High-throughput sequencing   [@ref44]
  *Escherichia coli* K-12 substrain MG1655                                                       The authors analyzed the extracellular RNA complement of both outer membrane vesicle (OMV)-associated and OMV-free RNAs.                                                                                                                                                                                                                                                                                                                   High-throughput sequencing   [@ref25]
  *Vibrio cholerae* strain A1552 (O1 El Tor strain)                                              The authors characterized the RNA profiles of bacterial OMVs and found that RNA is among the wide variety of bacterial components associated with OMVs.                                                                                                                                                                                                                                                                                    High-throughput sequencing   [@ref65]
  *Pseudomonas aeruginosa*                                                                       Authors characterized differentially packaged sRNAs in OMVs that they transferred into human airway cells. One candidate sRNA (sRNA52320) was further studied based on its stable secondary structure and predicted mRNA targets.                                                                                                                                                                                                          High-throughput sequencing   [@ref37]
  *Escherichia coli* strain 536                                                                  The authors employed density gradient centrifugation to fractionate and characterize OMVs and they found that they carry a range of RNA species. The authors reported the first complete bacterial OMV-associated RNA profile by using RNA-sequencing of libraries derived from three different "size" RNA populations (\<50 nt, 50--200 nt and 200 nt+) isolated from OMVs.                                                               RNA-Seq (MySeq sequencing)   [@ref9]
  *Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis*, and *Treponema denticola*   The authors identified sRNAs using deep sequencing and characterized dozens of well conserved sRNAs through bioinformatic analysis. Highly expressed microbial sRNAs were selected for further validation. They also assessed the ability of bacterial OMVs to deliver sRNAs into eukaryotic cells and identify their potential effects on human immune-related target genes (i.e., suppression of certain cytokines in Jurkat T cells).   High-throughput sequencing   [@ref14]
  *Salmonella enterica* serovar Typhimurium (*S.* Typhimurium)                                   The authors analyzed that the extracellular RNA content specifically enriched in OMVs is made by mRNAs and other non-coding RNAs. The analysis of OMV-associated RNA indicated that some sRNAs are protected by OMVs and that they can be functionally active.                                                                                                                                                                             High-throughput sequencing   [@ref47]

Uptake of OMVs by Human Cells {#sec5}
=============================

One of the most exciting features of OMVs is their supposed function as mediators of the communication between bacteria, the environment, and host cells through the protection of their cargo and the delivery even to distant sites ([@ref13]; [@ref3]). Two types of OMVs cargos have been described and they include: (i) compounds incorporated into membranes or their components and (ii) compounds contained within the OMVs lumen such as nucleic acids (i.e., DNA and RNA; [@ref31]). It is widely accepted that several pathways promote the entry of OMVs: micropinocytosis, lipid raft-dependent or lipid raft-independent endocytosis, and clathrin‐ and caveolin-dependent entry ([@ref12]; [@ref54]; [@ref70]). The internalization of endocytic vesicles up to 1 μm in diameter is mediated *via* micropinocytosis, whereas clathrin‐ and lipid raft-mediated endocytosis are usually implicated for the uptake of smaller vesicles.

Recent studies have demonstrated that some molecules are responsible for the entry of OMVs into host cells. Among them, LPS and the O antigen structural region are critical for OMVs entry. OMVs lacking O antigen exploit clathrin-mediated endocytosis as the main route of entry, whereas the uptake of OMVs with intact O antigen is raft-dependent ([@ref55]). Other important molecules of OMVs surface, such as the pathogen-associated molecular patterns (PAMPs), can activate TLR signaling and facilitate the entry of OMVs into the host cells. In fact, it has been demonstrated that the activation of toll-like receptor 4 (TLR4) facilitates the delivery of LPS by OMVs into the cytosol ([@ref26]). Moreover, it has been observed that the OMVs membrane of *Legionella pneumophila* can fuse with eukaryotic membrane, thus mixing pathogen factors with the host cell membrane ([@ref30]). Therefore, owing to the presence of different molecules, bacterial OMVs may have specific and distinct delivery routes to host cells. However, the uptake is a "multifactorial" process as it depends on many factors (for example, size, composition of the membrane and structure of its components, environmental temperature, etc.,). The complete understanding of all these parameters will help to reveal not only the biological processes that underline the guest-host communication processes, but also to devise new strategies to inhibit the action of pathogenic bacteria, facilitate the entry of OMVs for biomedical applications, and design a novel generation of powerful OMV-based engineered delivery vectors.

Delivery of sRNAs by OMVs and Their Effect on Human Cells {#sec6}
=========================================================

OMVs from Gram-negative bacteria mediate various bacteria-bacteria interactions ([@ref78]) nutrient acquisition, biofilm development and pathogenesis ([@ref41]), antibiotic resistance ([@ref61]), and killing of competing bacteria by directly stimulating target cells or delivering their cargos. More recently, many studies focused on the role of OMVs and their ability to enter human cells and interact with the host ([@ref52]; [@ref57]; [@ref15]). Although virulence factors and other molecules can be delivered by OMVs to host cells ([@ref39]; [@ref20]), little is still known about the role (i.e., fate and function) of sRNAs contained within OMVs once delivered into host cells. As we believe that the regulatory potential of RNA molecules, including microRNAs, can have a significant impact on modulating critical biological processes in human cells, ultimately affecting human health, we focused the discussion on the most recent studies reported in the literature dealing with the delivery of OMVs containing sRNAs molecules.

In a quite recent study, Koeppen and collaborators characterized the RNA content of OMVs from *P. aeruginosa* by RNA-Seq ([@ref37]). Among the differentially packaged sRNAs, they studied *sRNA52320*, a fragment of a methionine tRNA. This sRNA is abundant in OMVs and has a stable secondary structure. The authors studied the transfer of this sRNA to human airway cells and observed a reduction of IL-8 levels as *sRNA52320* was predicted to target MAP-kinases mRNA ([@ref37]).

Choi and collaborators, investigated the effect of msRNAs contained in three periodontal pathogens (i.e., *A. actinomycetemcomitans*, *P. gingivalis*, and *T. denticola*) and demonstrated the uptake of OMVs by host cells ([@ref15]). The authors selected one highly expressed msRNA from each periodontal pathogen and examined the levels of 16 cytokines after transfection of a synthetic msRNA oligo in Jurkat cells. They observed that the msRNAs secreted into OMVs by these periodontal pathogens were able to affect the host immune system by decreasing the expression level of IL-5, IL-13, and IL-15. Many studies in the past have linked periodontal diseases to neuroinflammation without elucidating the mechanisms of this relationship. Therefore, to explore this link, another work focused on periodontal pathogens and the role of OMV-derived RNAs, thus providing evidence about the activity of OMV-derived sRNAs in host gene regulation ([@ref27]). The authors demonstrated the increased production of TNF-α promoted by OMV-derived sRNAs *via* the TLR-8 and NF-κB signaling pathways. Interestingly, the intracardiac injection of OMVs in mice resulted in the successful delivery also into the brain (after BBB crossing) followed by an increased expression of TNF-α.

Although limited, these lines of evidence suggest a functional similarity of bacterial OMVs and mammalian exosomes. Similarly to exosomes that harbor miRNAs, bacterial OMVs possess sRNAs that are well protected by RNAses as demonstrated by several studies, in which OMVs RNAse treatment prior to RNA extraction did not prevent the recovery of RNA contained inside OMVs ([@ref65]; [@ref37]; [@ref15]). Additionally, bioinformatics approaches demonstrated that many abundant RNAs contained within OMVs are able to form stable secondary structures very similar to those of precursor miRNAs. Moreover, the sRNAs identified in *E. coli* OMVs may function through a RNA interference mechanism by pairing with complementary target genes ([@ref48]).

In conclusion, it has been demonstrated that sRNAs stably incorporated within OMVs can be transferred to other bacteria or to host tissues and may play a critical regulatory role similarly to exosomal miRNAs. However, only few examples of interspecies communication *via* extracellular sRNAs appeared so far in the literature. Undoubtedly, the identification of such pathways and their species conservation strongly outline the fact that the communication through sRNAs contained into OMVs represents an important but still unexplored issue.

Conclusions and Perspectives {#sec7}
============================

Despite numerous papers demonstrated the effects of OMVs on human cells, either mediated by proteins or nucleic acids, the exact mechanisms of bacterial vesicles and their content are still largely unknown. Some of us, after the paper of Liu and coworkers ([@ref46]) that reported the ability of human exosomes to regulate bacterial gene expression, suggested that bacterial vesicles might, in turn, regulate the human transcriptome and potentially induce epigenetic modifications ([@ref13]).

As a significative example of how this concept could be valid also in other systems, we downloaded the raw data reported by Choi and colleagues ([@ref14]), and we followed the same experimental bioinformatics procedures that we have already discussed in one of our previous paper ([@ref13]). We found that the reads belonging to the three periodontal pathogens aligned against some histone mark regions of the human genome, as previously observed also for the sRNA contained in the OMVs of *E. coli* ([Figure 1](#fig1){ref-type="fig"}; [@ref13]). These results suggested not only that these small bacterial RNAs have some similarities with regulatory regions of the human genome, but also that these molecules could function similarly to other long non-coding RNAs, already characterized in humans but still underexplored in bacteria. Therefore, we believe that these exciting findings should prompt further investigations to unravel completely the potential regulatory effects that these bacterial sRNAs might have on human cells.

![UCSC genome browser depicts one representative genomic region where the bacterial small RNAs (sRNAs) (the reads) of the three periodontal pathogens align. Brown boxes represent bacterial reads aligned (Bowtie2 with default parameters) against the human genome; the multi-view composite tracks (colored regions) reported below indicate the occurrence of ENCODE Histone Modification Track H3K27Ac found in different cell types (colored in cyan, green, yellow, red, magenta, and violet). Human genome assembly as of December 2013 (GRCh38/hg38).](fmicb-11-01209-g001){#fig1}

Owing to the relevant regulatory potential that these bacterial sRNAs might have and the potential application of bacterial OMVs in many biomedical fields, we think that further studies should focus particularly on understanding the functions and the molecular mechanisms of these sRNAs. Moreover, we think that by studying the secondary structure of bacterial sRNAs and the similarities with other human coding and non-coding RNAs, we should be able to completely understand their function once entered into human cells. Moreover, it would be crucial to learn how to modulate important biological processes (and diseases) by engineering bacteria to produce OMVs with a specific RNA content.
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